title: Is apolipoprotein e required for cognitive function in humans?: implications for Alzheimer drug development.
authors.affiliation: Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas2Center for Alzheimer's and Neurodegenerative Diseases, University of Texas Southwestern Medical Center, Dallas.
authors.forename: Courtney
authors.initials: C
authors.lastname: Lane-Donovan
authors.affiliation: Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas2Center for Alzheimer's and Neurodegenerative Diseases, University of Texas Southwestern Medical Center, Dallas3Department of Neuroscience, University of Texas Southw.
authors.forename: Joachim
authors.initials: J
authors.lastname: Herz
mesh_terms: D001057:Apolipoproteins E / Q000235:genetics*; D006801:Humans; D006952:Hyperlipoproteinemia Type III / Q000235:genetics*; D008049:Lipase / Q000235:genetics*; D008297:Male; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics*
chemical_list: D001057:Apolipoproteins E; D008049:Lipase; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins; C504173:LIPC protein, human
references.citation: J Clin Invest. 1994 Aug;94(2):860-9
references.pmid: 8040342
references.citation: J Biol Chem. 2010 Oct 29;285(44):34144-54
references.pmid: 20739291
references.citation: Biochim Biophys Acta. 1987 Jan 13;917(1):148-61
references.pmid: 3539206
references.citation: Neurosci Lett. 1995 Oct 13;199(1):1-4
references.pmid: 8584214
references.citation: J Lipid Res. 1998 Aug;39(8):1594-600
references.pmid: 9717719
references.citation: Brain Res. 1997 Mar 21;751(2):307-14
references.pmid: 9099820
references.citation: Nat Genet. 1997 Nov;17(3):263-4
references.pmid: 9354781
references.citation: Neuroscience. 1998 Jul;85(1):93-110
references.pmid: 9607706
references.citation: FASEB J. 2001 Dec;15(14):2623-30
references.pmid: 11726538
references.citation: Exp Neurol. 1995 Dec;136(2):107-22
references.pmid: 7498401
references.citation: Science. 2010 Dec 24;330(6012):1774
references.pmid: 21148344
references.citation: Science. 1992 Oct 16;258(5081):468-71
references.pmid: 1411543
references.citation: Sci Transl Med. 2011 Jun 29;3(89):89ra57
references.pmid: 21715678
references.citation: J Neurosci. 2014 May 21;34(21):7281-92
references.pmid: 24849360
references.citation: J Neurosci. 2009 May 27;29(21):6771-9
references.pmid: 19474305
references.citation: J Clin Invest. 1986 Nov;78(5):1206-19
references.pmid: 3771793
references.citation: Science. 1993 Aug 13;261(5123):921-3
references.pmid: 8346443
references.citation: Neuron. 2014 May 21;82(4):756-71
references.pmid: 24853936
references.citation: Nat Rev Immunol. 2013 Dec;13(12):875-87
references.pmid: 24157572
references.citation: Am J Geriatr Psychiatry. 2008 May;16(5):343-54
references.pmid: 18448847
references.citation: J Neurosci. 2011 Dec 7;31(49):18007-12
references.pmid: 22159114
references.citation: Science. 2012 Mar 23;335(6075):1503-6
references.pmid: 22323736
references.citation: Sci Transl Med. 2013 Nov 20;5(212):212ra161
references.pmid: 24259049
references.citation: JAMA Neurol. 2014 Jan;71(1):11-22
references.pmid: 24276092
references.citation: JAMA Neurol. 2014 Oct;71(10):1228-36
references.pmid: 25111166
references.citation: Nat Genet. 1994 Jun;7(2):180-4
references.pmid: 7920638